SCHEMBL3363076

SCHEMBL3363076

Cc1ccc(NC(O)c2c(-c3ccc(Cl)cc3)nc3ccc(C)cn23)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
TP53 P04637 5/20 0.48
GAA P10253 4/20 0.48
NR1H4 Q96RI1 3/20 0.45
ALOX5 P09917 1/20 0.39
EPHX2 P34913 1/20 0.39
PKM P14618 1/20 0.39
PKLR P30613 1/20 0.39
POLB P06746 1/20 0.38
GABRB1 P18505 2/20 0.38
GABRD O14764 1/20 0.38
GABRA4 P48169 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
ALB P02768 1/20 0.36
CYP3A4 P08684 1/20 0.36
CHRM1 P11229 1/20 0.36
GABRA1 P14867 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3393907 0.89 TP53 (0.45) MAPTTP53GAANR1H4PKM
SCHEMBL3360536 0.89 TP53 (0.40) MAPTTP53GAANR1H4ALOX5
SCHEMBL3391218 0.87 MAPT (0.45) MAPTTP53GAAALDH1A1KDM4E
SCHEMBL3396264 0.86 CRHR1 (0.38) MAPTTP53GAANR1H4PKM
SCHEMBL3434736 0.85 NR1H4 (0.49) TP53GAANR1H4ALDH1A1KDM4E
SCHEMBL3394856 0.83 GAA (0.39) MAPTTP53GAANR1H4ALOX5
SCHEMBL14632083 0.83 GABRD (0.38) MAPTTP53GAAGABRB1GABRD
SCHEMBL3392717 0.81 SLC2A1 (0.45) MAPTTP53GAAALOX5EPHX2
SCHEMBL3393270 0.80 NR1H4 (0.51) MAPTGAANR1H4ALOX5ALDH1A1
SCHEMBL1692153 0.79 TP53 (0.55) MAPTTP53GAANR1H4PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 MAPT 3076/4885TP53 2306/4885GAA 114/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT MAPT 2195/4885TP53 1815/4885GAA 474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.